Overall survival and event-free survival was significantly worse in patients with AML with detectable/high MECOM expression (supplemental Figure 3D), underscoring the importance of MECOM’s gene regulatory activity in relation to patient survival, as has been reported previously.38 Here, MECOM is linked to acute myeloid leukemia.